+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Bladder Scanner Market Size and Share Outlook - Forecast Trends and Growth Analysis Report (2025-2034)

  • PDF Icon

    Report

  • 350 Pages
  • July 2025
  • Region: Global
  • Expert Market Research
  • ID: 6163010
The global bladder scanner market size was valued at USD 148.02 Billion in 2024, driven by the rising prevalence of urological diseases like urinary tract infections and urinary incontinence across the globe. The market is expected to grow at a CAGR of 5.50% during the forecast period of 2025-2034, with the values likely to rise from USD 252.84 Billion by 2034.

Bladder Scanner: Introduction

A bladder scanner is a portable diagnostic tool used to perform non-invasive and quick bladder scan. It is mostly done to detect health issues like urinary tract infections, VUR (vesicoureteral reflux, where the urine flows back from bladder to kidney), incomplete bladder emptying, urinary incontinence and swelling. The device is equipped with an ultrasound probe, and a transducer, which reflects sound waves from patient's bladder into the scanner. The data is then transferred to the computer for calculating the bladder volume.

Global Bladder Scanner Market Analysis

With the incidence of urological issues like urinary incontinence, vesicoureteral reflux, bladder cancer, and urinary tract infections, the need for diagnostics to treat and prevent the diseases effectively has increased. Cystoscopy serves as an effective tool to analyze any abnormality in the bladder. It is used to detect lesions and other pathologies in the bladder. When compared to traditional methods, bladder scanning is a painless and non-invasive method that eliminates the risk associated with catheterization. Hence, the bladder scanner market demand has seen a substantial upswing in recent years.

In the contemporary age, automation, precision, affordability, and time management have been the key areas of interest for any scientist designing a new product. Therefore, portable, and handheld bladder scanners have emerged in the market. With artificial intelligence driven features, handheld devices can offer great assistance in various daily urologic scenarios, which include upper as well as lower urinary tracts. Vscan™ by GE Healthcare is enabled with an application that offers edge-detection algorithm that suggests and automatically places measure calipers to facilitate a view from transverse and sagittal plane.

Bladder scanners find its utility in urological as well as obstetrics-gynecological domain. EchoNous bladder scanner combines a superlative probe design with a Convolutional Neural Networks (CNNs) algorithm, making it suitable to check the bladder volume in pregnant as well as post-partum patients. As technology continues to evolve, we can expect new technologies designed to make patient treatment and efficient, resulting in positive bladder scanner market value in the forecast period.

Global Bladder Scanner Market Segmentation

Bladder Scanner Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:

Market Breakup by Product

  • Bench Top Bladder Scanners
  • Portable Bladder Scanners
  • Handheld Bladder Scanners

Market Breakup by Application

  • Urology
  • Obstetrics-Gynaecology
  • Rehabilitations
  • Others

Market Breakup by End User

  • Hospitals
  • Diagnostic Centres
  • Urology Clinics
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Bladder Scanner Market Overview

Around 423 million people in the world experience urinary incontinence in some form or another. Overflow urinary incontinence is often linked to neurologic diseases like spinal cord injuries and diabetes. In addition, bladder cancer is the 10th most commonly occurring cancer working. Therefore, burden of cancer combined with the incidence of diabetes, urinary tract infections, chronic kidney diseases are key drivers for bladder scanner market growth.

Due to the presence of high expenditure on healthcare research and development, the United States is expected to contribute significantly to the overall bladder scanner market share. This can be attributed to the rising prevalence of urological disorders and bladder cancer cases. The fastest growth can be observed in the Asia Pacific region as they contribute to the world's largest geriatric population.

In addition, the rising number of pregnancies will also require bladder scanners. There has been significant emphasis on providing awareness about diagnostics for early detection of chronic diseases, which will aid the growth in the forecast period.

Global Bladder Scanner Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • GE Healthcare Inc.
  • Vitacon
  • dbMEDx
  • Roper Technologies Inc. (Verathon Inc.)
  • Mcube Technology Co. Ltd
  • BD
  • EchoNous, Inc.
  • MEDA Co., Ltd.
  • Laborie, Inc.
  • INTEGRA LIFESCIENCES CORP.
  • SRS Medica

This product will be delivered within 3-5 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Bladder Scanner Market Overview
3.1 Global Bladder Scanner Market Historical Value (2018-2024)
3.2 Global Bladder Scanner Market Forecast Value (2025-2034)
4 Global Bladder Scanner Market Landscape
4.1 Global Bladder Scanner Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Bladder Scanner Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Application
5 Global Bladder Scanner Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Bladder Scanner Market Segmentation
6.1 Global Bladder Scanner Market by Product
6.1.1 Market Overview
6.1.2 Bench Top Bladder Scanners
6.1.3 Portable Bladder Scanners
6.1.4 Handheld Bladder Scanners
6.2 Global Bladder Scanner Market by Application
6.2.1 Market Overview
6.2.2 Urology
6.2.3 Obstetrics-Gynecology
6.2.4 Rehabilitations
6.2.5 Others
6.3 Global Bladder Scanner Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Diagnostic Centers
6.3.4 Urology Clinics
6.3.5 Others
6.4 Global Bladder Scanner Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Bladder Scanner Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Bladder Scanner Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Bladder Scanner Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Bladder Scanner Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Bladder Scanner Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 GE Healthcare Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Vitacon
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 dbMEDx
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Roper Technologies Inc. (Verathon Inc.)
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Mcube Technology Co. Ltd
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 BD
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 EchoNous, Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 MEDA Co., Ltd.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Laborie, Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 INTEGRA LIFESCIENCES CORP.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 SRS Medical
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
18 Global Bladder Scanner Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • GE Healthcare Inc.
  • Vitacon
  • dbMEDx
  • Roper Technologies Inc. (Verathon Inc.)
  • Financial Portfolio
  • Mcube Technology Co. Ltd
  • BD
  • EchoNous, Inc.
  • MEDA Co., Ltd.
  • Laborie, Inc.
  • INTEGRA LIFESCIENCES CORP.
  • SRS Medical